Wray Justin, Amdur Robert J, Christopherson Kaitlin M, Morris Christopher G, Dziegielewski Peter T, Boyce Brian J, Mendenhall William M
Departments of Radiation Oncology.
Otolaryngology, University of Florida, Gainesville, FL.
Am J Clin Oncol. 2018 Dec;41(12):1216-1219. doi: 10.1097/COC.0000000000000461.
Patients with mucosal squamous cell carcinoma (SCC) of the head and neck almost always have a primary site in the base of tongue or tonsillar fossa. Lingual tonsillectomy has recently been advocated as part of the diagnostic evaluation as opposed to directed biopsies of the base of tongue and thought to possibly result in an increased likelihood or cure. The purpose of this project is to determine whether this is probable.
We reviewed the medical records of patients treated with primary radiotherapy (RT) between January 1983 and March 2013. The outcomes were compared following RT in consecutively treated patients with either T1-2 base of tongue or unknown primary (cancer of unknown primary) SCC with predominantly level 2 adenopathy.
At 10 years, there were no clinically significant differences in the 2 groups, in local control, regional control, freedom from distant metastases, disease-specific, or cause-specific survival. Overall survival at 10 years was improved with T1-2 base of tongue cancers but not for those with T0 N3 disease. The reasons for this are unclear.
Tongue base biopsy (or lingual tonsillectomy) likely increases the probability of identifying an unknown primary in the base of tongue, but it does not improve outcome following RT for patients with cancer of unknown primary SCC with predominantly level 2 adenopathy.
头颈部黏膜鳞状细胞癌(SCC)患者的原发部位几乎总是在舌根或扁桃体窝。最近有人主张将舌扁桃体切除术作为诊断评估的一部分,而不是对舌根进行定向活检,并认为这可能会增加治愈的可能性。本项目的目的是确定这是否可行。
我们回顾了1983年1月至2013年3月期间接受原发放疗(RT)的患者的病历。对连续接受治疗的T1-2期舌根或原发灶不明(不明原发癌)的SCC且主要为2区淋巴结肿大的患者放疗后的结果进行了比较。
10年时,两组在局部控制、区域控制、无远处转移、疾病特异性或病因特异性生存率方面无临床显著差异。T1-2期舌根癌患者10年总生存率有所提高,但T0 N3期患者则没有。原因尚不清楚。
舌根活检(或舌扁桃体切除术)可能会增加发现舌根不明原发灶的概率,但对于主要为2区淋巴结肿大的不明原发SCC癌患者,放疗后并不能改善其预后。